fazTimes media: New Delhi — A new study has raised major worries about glipizide, a widely used drug for type 2 diabetes. It has been linked to a higher chance of heart-related problems. The results, which were published in the journal JAMA Network Open, are already making news around the world and causing medical debate in India, where millions of people have diabetes. A team from Mass General Brigham looked at health records from almost 50,000 patients across the United States. They discovered that people taking glipizide had a much higher rate of heart failure, hospitalizations, and even death than people taking newer drugs like DPP-4 inhibitors.

Why this is important for India

The International Diabetes Federation says that over 77 million people in India have type 2 diabetes, making the country known as the "diabetes capital of the world." Many people are given sulfonylurea drugs like Glipizide because they are cheap and easy to get at both public and private hospitals.

However, this new study prompts both doctors and patients to reevaluate the long-term safety of these drugs. According to BBC News, the study's authors stress that while sulfonylureas have been shown to help control blood sugar, not all of these drugs are equally safe for the heart.

A Quick Look at the Study

The researchers kept an eye on 48,165 people with type 2 diabetes who were already taking metformin, which is usually the first treatment used. The people in the study had a modest risk of heart disease and were getting care from ten different US health care networks.

The patients were then watched for five years to see if they had any major heart problems, such as heart failure, strokes, or hospital stays. The results told us a lot:

People who took glipizide had a 13% higher risk of heart problems than people who took DPP-4 inhibitors like sitagliptin or linagliptin.
A smaller and less reliable link was found between glimepiride and heart problems compared to other sulfonylureas.

What experts think

Dr. Alexander Turchin, an endocrinologist at Brigham and Women's Hospital and the principal investigator of the research, said, "People with type 2 diabetes are already more likely to have heart attacks and strokes." "Our results suggest that glipizide may make that risk even higher, especially in people who already have heart problems."

Al Jazeera reports that doctors are now calling for more care when giving drugs to older adults or people who are more likely to abuse their drugs.

Dr. Sushil Rathi, a top endocrinologist at Fortis Hospital in Mumbai, said, "This study makes it clear that we shouldn't treat all sulfonylureas the same." Each patient's medical makeup is important, especially if they have other health problems, like heart disease.

Prices that are fair vs. safety

One of the primary problems for Indian people is how much health care costs. DPP-4 inhibitors are thought to be safer than other drugs like glipizide, but they can cost three to five times as much. This makes it harder for people living in rural areas or without health insurance to access them.

Dr. Rathi says, "We can't ignore the facts of the economy." "But informed giving, which takes into account a person's overall health, heart risk, and ability to keep up with regular checkups, can help close the gap."

What Should People Do?

It's not necessary to worry if you are taking glipizide. Doctors stress that patients should not stop taking any medications without first talking to a physician.

Sick people can do what's listed below:

Talk About Options: Ask your doctor if you can take newer medicines based on your health and how much money you have.
Check Your Heart Health: It's more important to get regular checkups, ECGs, and blood pressure checks.
Find out how risky it is. If you have had heart disease, a stroke, or high blood pressure in the past, taking glipizide may increase your risk further.
The Balanced Lifestyle: Medicine is just one way to deal with diabetes. Eating well, working out regularly, and lowering stress are all important too.

What does the discovery mean for the future and policy?

India's health planning could change in many ways because of this study's results. The government runs programs like Ayushman Bharat that try to give away or help people get drugs. As a result, it is increasingly important to consider factors beyond just the price.

Policymakers should use this kind of data, according to Dr. K. D. Nayar, an expert on public health in India. We must ensure the constant availability of safe and affordable drugs. Some experts are also calling for more studies focused specifically on India. "We need to look into how well glipizide and other similar drugs work with Indians, who have different eating habits, weather, and genetic traits," says Dr. Nayar.

A Call for Well-Informed Decisions

There has been an argument about cost and level of care for a long time, but this study makes it more important than ever. India is still trying to fight its diabetes crisis, and both doctors and people need to know about the best and safest ways to treat the disease.

At FazTimes, we prioritize accuracy, confidence, and strong journalistic standards. To ensure every news story we share is real, we verify it with multiple trustworthy and independent sources.

We’ve compared this report with coverage from major news outlets around the world, including BBC News, Reuters, Bloomberg, South China Morning Post, Al Jazeera, NDTV, The Economic Times, and The Indian Express.

Our dedication lies in upholding the highest standards in global journalism, ensuring our readers can trust the information they receive.